Prasad G Kilaru, | |
39141 Civic Center Dr, Suite 110, Fremont, CA 94538-1730 | |
(510) 791-9700 | |
(510) 791-9703 |
Full Name | Prasad G Kilaru |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 34 Years |
Location | 39141 Civic Center Dr, Fremont, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689674665 | NPI | - | NPPES |
00A601040 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2082S0105X | Plastic Surgery - Surgery Of The Hand | A060104 (California) | Secondary |
208200000X | Plastic Surgery | A060104 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Washington Hospital | Fremont, CA | Hospital |
Entity Name | East Bay Hand & Plastic Surgery Center Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720214125 PECOS PAC ID: 3173675030 Enrollment ID: O20090723000599 |
News Archive
Mycobacterium ulcerans infects the skin and subcutaneous tissues and secretes a lipid toxin, mycolactone, which causes open skin lesions, known as Buruli ulcers.
Treatment with a commonly used drug slows the decline in lung function in patients with chronic obstructive pulmonary disease (COPD), according to results from the TORCH (TOwards a Revolution in COPD Health) study presented at the American Thoracic Society 2007 International Conference, on Tuesday, May 22.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
KCI applauds the FDA for launching this important initiative to ensure that complex medical devices are used safely in the home by caregivers and patients. We have made it our priority and unwavering responsibility to help caregivers and patients understand how to use our advanced treatments safely. This includes offering a robust education and training program, employing highly trained clinical support staff and providing easy-to-read, patient-specific labeling.
› Verified 7 days ago
Entity Name | Washington Township Medical Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346557014 PECOS PAC ID: 2860687050 Enrollment ID: O20101112001225 |
News Archive
Mycobacterium ulcerans infects the skin and subcutaneous tissues and secretes a lipid toxin, mycolactone, which causes open skin lesions, known as Buruli ulcers.
Treatment with a commonly used drug slows the decline in lung function in patients with chronic obstructive pulmonary disease (COPD), according to results from the TORCH (TOwards a Revolution in COPD Health) study presented at the American Thoracic Society 2007 International Conference, on Tuesday, May 22.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
KCI applauds the FDA for launching this important initiative to ensure that complex medical devices are used safely in the home by caregivers and patients. We have made it our priority and unwavering responsibility to help caregivers and patients understand how to use our advanced treatments safely. This includes offering a robust education and training program, employing highly trained clinical support staff and providing easy-to-read, patient-specific labeling.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Prasad G Kilaru, 39141 Civic Center Dr, Suite 110, Fremont, CA 94538-1730 Ph: (510) 791-9700 | Prasad G Kilaru, 39141 Civic Center Dr, Suite 110, Fremont, CA 94538-1730 Ph: (510) 791-9700 |
News Archive
Mycobacterium ulcerans infects the skin and subcutaneous tissues and secretes a lipid toxin, mycolactone, which causes open skin lesions, known as Buruli ulcers.
Treatment with a commonly used drug slows the decline in lung function in patients with chronic obstructive pulmonary disease (COPD), according to results from the TORCH (TOwards a Revolution in COPD Health) study presented at the American Thoracic Society 2007 International Conference, on Tuesday, May 22.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
KCI applauds the FDA for launching this important initiative to ensure that complex medical devices are used safely in the home by caregivers and patients. We have made it our priority and unwavering responsibility to help caregivers and patients understand how to use our advanced treatments safely. This includes offering a robust education and training program, employing highly trained clinical support staff and providing easy-to-read, patient-specific labeling.
› Verified 7 days ago
Dr. Ario Barzin, M.D, Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3200 Kearney Street, Fremont, CA 94538 Phone: 510-490-1222 | |
John Anthony Romano, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 686 Mowry Ave, Fremont, CA 94536 Phone: 510-794-5010 Fax: 510-794-5143 |